Literature DB >> 23021062

A practical approach to improve safety and management in chemotherapy units based on the PROCHE - programme for optimisation of the chemotherapy network monitoring program.

Florian Scotté1, Stéphane Oudard, Hail Aboudagga, Reza Elaidi, Brigitte Bonan.   

Abstract

The PROCHE (PRogramme d'Optimisation du circuit CHimiothErapie [Programme for optimisation of the chemotherapy network]) initiative is an innovative oncology-monitoring program designed to reduce patient waiting time and chemotherapy wastage, ultimately improving patient care. Laboratory test results and side effects data were collected for patients in the PROCHE monitoring program group 2d prior to scheduled chemotherapy visits, allowing oncologists to confirm or delay each patient's chemotherapy. Data from 1037 patients entered in the PROCHE program were compared with 513 control patients, who had been treated according to previous typical hospital procedures. Results demonstrated significant reductions in mean hospital stay i.e. decreased it by 66 min and drug wastage decreased from 6% to 2% (95% CI (confidence interval) 0.21-0.59, P<0.0001), and a significant increase in bed occupancy rates with the PROCHE initiative (all P<0.0001 vs. controls). The incidence of pain and severity of fatigue were also reduced. In conclusion, the PROCHE initiative resulted in improved patient quality of care and reduced chemotherapy toxicities, and improved hospital and pharmacy productivity. These encouraging preliminary results warrant further study.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23021062     DOI: 10.1016/j.ejca.2012.08.025

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  How well Informed are Cancer Patients Prior to a Life Cycle of Injectable Chemotherapy Drug Treatment?

Authors:  Marion Jobard; Karine Sejean; Coralie Lepage-Seydoux; Brigitte Bonan
Journal:  J Cancer Educ       Date:  2018-02       Impact factor: 2.037

2.  Mobile Phone Based System Opportunities to Home-based Managing of Chemotherapy Side Effects.

Authors:  Somayeh Davoodi; Zeinab Mohammadzadeh; Reza Safdari
Journal:  Acta Inform Med       Date:  2016-06-04

3.  Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients.

Authors:  Yann-Alexandre Vano; Stéphane Oudard; Marie-Agnès By; Pauline Têtu; Constance Thibault; Hail Aboudagga; Florian Scotté; Reza Elaidi
Journal:  PLoS One       Date:  2018-04-06       Impact factor: 3.240

Review 4.  Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper.

Authors:  Tim Cooksley; Carme Font; Florian Scotte; Carmen Escalante; Leslie Johnson; Ronald Anderson; Bernardo Rapoport
Journal:  Support Care Cancer       Date:  2020-11-23       Impact factor: 3.603

5.  Oncologic Home-Hospitalization Delivers a High-Quality and Patient-Centered Alternative to Standard Ambulatory Care: Results of a Randomized-Controlled Equivalence Trial.

Authors:  Lieselot Cool; Jana Missiaen; Philip Debruyne; Hans Pottel; Veerle Foulon; Tessa Lefebvre; Laura Tack; Petra Archie; Dominique Vandijck; Koen Van Eygen
Journal:  JCO Glob Oncol       Date:  2021-09

6.  Applying Value Stream Mapping to Improve the Delivery of Patient Care in the Oncology Day Hospital.

Authors:  Pilar I Vidal-Carreras; Julio J Garcia-Sabater; Juan A Marin-Garcia
Journal:  Int J Environ Res Public Health       Date:  2022-04-02       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.